ロード中...
Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma
Osteosarcoma is an aggressive cancer with a poor long term prognosis. Neo-adjuvant poly-chemotherapy followed by surgical resection remains the standard treatment, which is restricted by multi-drug resistance. If first-line therapy fails, disease control and patient survival rate drop dramatically....
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6152475/ https://ncbi.nlm.nih.gov/pubmed/30250645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26038 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|